3 recruiting, 1 active not recruiting. 4 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Recruiting 3, Active not recruiting 1 |
| Phase 2 | 2 | Recruiting 2 |
Follow AP Biosciences Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of AP601 in Patients With Locally Unresectable Advanced or Metastatic Solid Tumors AP601 - Solid Tumours | Phase 1 | Recruiting | AP Biosciences Inc. | 36 | 2026-01-21 | 2025-12-29 |
| A Study of AP402 in HER2-Positive Patients With Locally or Advanced Solid Tumors AP402 (Part 1 Dose esclation), AP402 (Part 2 Dose Expansion) - Advanced Solid Tumor | Phase 1 / Phase 2 | Recruiting | AP Biosciences Inc. | 85 | 2025-04-22 | 2025-04-25 |
| A Study to Investigate the Safety, Pharmacokinetics, and Clinical Activity of AP203 in Patients with Locally Advanced or Metastatic Solid Tumors, and Expansion to Selected Malignancies AP203 - Locally Advanced or Metastatic Solid Tumors, Non Small Cell Lung Cancer (NSCLC) | Phase 1 / Phase 2 | Recruiting | AP Biosciences Inc. | 168 | 2023-07-24 | 2025-03-26 |
| A Study of AP505 Injection in Patients With Advanced Malignant Solid Tumors AP505 - Advanced Solid Tumors | Phase 1 | Active not recruiting | AP Biosciences Inc. | 35 | 2023-03-30 | 2024-12-09 |
Carcinoma, Non-Small-Cell Lung (1) · Esophageal Squamous Cell Carcinoma (1) · Squamous Cell Carcinoma of Head and Neck (1)
Australia (2) · Taiwan (2)